AdaptHealth Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by AdaptHealth Corp. on June 22, 2022. The meeting was conducted via live audio webcast. As of the record date (April 26, 2022), 95,985,184 shares of Common Stock were present or represented by proxy, constituting 71.49% of the voting power and establishing a quorum.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on four proposals, all of which were approved:
- Election of Class III Directors: Brad Coppens, Dr. Susan Weaver, and Dale Wolf were elected for three-year terms. Dr. Weaver received the highest support (75,287,752 votes for), while Mr. Wolf received the lowest (66,925,485 votes for).
- Ratification of Auditors: KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2022, with 95,689,467 votes in favor.
- Executive Compensation (Say-on-Pay): Stockholders approved the compensation paid to named executive officers with 83,592,013 votes in favor.
- Frequency of Say-on-Pay Vote: Stockholders approved conducting the advisory vote on executive compensation annually (one year), with 84,602,870 votes for the one-year option.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the specific terms of the newly elected directors' service until the 2025 annual meeting.
- Confirm the appointment of KPMG LLP for the 2022 fiscal year audit.
- Note the shareholder preference for annual executive compensation advisory votes.
- Review the definitive proxy statement filed on May 2, 2022, for detailed background on the proposals.